Trinity researchers, along with UK collaborators, have created a simple but powerful diagnostic tool, which they believe will ...

Dupixent (dupilumab) has been a breakthrough treatment for people with severe eczema, asthma, and other inflammatory ...

A new study carried out in Birmingham has given hope to people who suffer from a rare form of skin cancer.

Toasted skin syndrome causes a net-like rash to appear where the skin has been exposed to a heat source. It may resolve on ...

Discover how T-cell receptor clonotype biomarkers help identify high-risk MF/SS patients, improving risk stratification and ...

When you start a medication like Dupixent (dupilumab), you expect relief from eczema or asthma, not the devastation of a cancer diagnosis. Yet ...

CHICAGO — Enpatoran, a first-in-class oral small molecule toll-like receptor 7/8 inhibitor, is superior to placebo in ...

HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced that a newly published clinical case study has demonstrated the successful use of its 308-nanometer excimer laser in treating a rare ...

The event will provide clinical perspectives and market outlook for lacutamab, Innate’s lead proprietary product progressing towards potential accelerated approval in SS and confirmatory phase 3 ...

Of all the pesky and uncomfortable things that can happen to your body, itching definitely ranks pretty high on the list. And when you have itchy skin all over? Talk about annoying (and inconvenient).

On Wednesday, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals Inc.’s (NASDAQ:REGN) PD-1 inhibitor Libtayo (cemiplimab-rwlc) as an adjuvant treatment for adult patients ...